MZMeizhen Zhu

Meizhen Zhu

*This is an algorithmically generated author record based on publicly available information.

Meizhen Zhu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Chenlu Liang

    Chinese Acad Sci, Hangzhou Inst Med HIM, Zhejiang Canc Hosp, Breast Canc Dept, Hangzhou 310022, Zhejiang, Peoples R China

    2 shared publications
  • Jiejie Hu

    Chinese Acad Sci, Hangzhou Inst Med HIM, Zhejiang Canc Hosp, Breast Canc Dept, Hangzhou 310022, Zhejiang, Peoples R China

    2 shared publications
  • Yang Yu

    Department of Breast Surgery, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China

    2 shared publications
  • Chengdong Qin

    Chinese Acad Sci, Hangzhou Inst Med HIM, Zhejiang Canc Hosp, Breast Canc Dept, Hangzhou 310022, Zhejiang, Peoples R China

    1 shared publication
  • Fanrong Zhang

    Chinese Acad Sci, Hangzhou Inst Med HIM, Zhejiang Canc Hosp, Breast Canc Dept, Hangzhou 310022, Zhejiang, Peoples R China

    1 shared publication
  • Jiefei Mao

    Chinese Acad Sci, Hangzhou Inst Med HIM, Zhejiang Canc Hosp, Breast Canc Dept, Hangzhou 310022, Zhejiang, Peoples R China

    1 shared publication

Latest Publications

  • Open Access

    Oncoplastic Breast-Conserving Surgery for Upper Inner Quadrant Breast Cancer Using Pedicled Pectoralis Major Myofascial Flap

    by Jie Jie Hu, Chengdong Qin, Siyuan Liu, Meizhen Zhu, Xianghou Xia, Chenlu Liang, Jiefei Mao, Fanrong Zhang, Yang Yu

    Background: Oncoplastic breast-conserving surgery (OBCS) has emerged as a pivotal approach in the management of breast cancer, ensuring both oncological safety and aesthetic outcomes. However, challenges persist, particularly in upper inner quadrant (UIQ) tumors, where achieving satisfactory cosmetic results while preserving oncological integrity remains intricate. Methods: 15 patients with UIQ breast cancer received OBCS using a pedicled pectoralis major myofascial flap (PMMF). All medical records, preoperative imaging findings, and post-operative data were gathered retrospectively. Results: This study showed good cosmetic outcomes after OBCS of the upper inner pole and the patients were satisfied with the results. There were no recurrences or metastases in any of the patients. Conclusion: PMMF as a technique is reliable blood supply, easy to master, no need for additional incision, and minimal surgical trauma and functional impact.


  • Open Access

    The Guiding Significance of the Number of Positive Sentinel Lymph Nodes in Frozen Section for Intraoperative Axillary Dissection in Early Breast Cancer

    by Chenlu Liang, Liuyi Li, Meizhen Zhu, Jiejie Hu, Yang Yu

    Purpose: The results of large randomised trials have changed the treatment strategy of axillary lymph nodes. Axillary lymph node dissection (ALND) can be avoided in some patients with one to two sentinel lymph nodes (SLNs) metastasis based on final paraffin section (FPS) results which called into question the need for intraoperative frozen section (FS). This study aims to assess the guiding value of the number of positive SLN detected via FS for intraoperative ALND. Patients and Methods: This study retrospectively analyzed data from 3303 patients with breast cancer who underwent SLN biopsy between 2015 and 2019. Combined with the FPS results, FS sensitivity, specificity, and false negative rate (FNR) were calculated and the difference in the number of positive SLNs between FS and FPS was analyzed. Results: The overall FNR of FS was 23.21%, which was 76.47% in isolated tumor cells, 62.28% in micrometastasis, and 12.09% in macrometastatic disease. The size of SLN metastasis were significantly associated with a higher FNR (p< 0.001). The accuracy rate of the number of positive SLNs detected via FS was 92.62%. Human epidermal growth factor receptor 2 (HER2) (p< 0.03) and Ki67 (p< 0.02) were significant factors affecting the accuracy rate. Conclusion: FS is a effective method for SLN biopsy, ALND can be avoided in patients with one or two positive SLNs detected via FS.